Amplification of the ERBB2 gene, encoding human epidermal growth factor receptor 2 (HER2), occurs in approximately 15% of primary breast cancers (PBC) and causes overexpression of the protein kinase receptor HER2. This evidence concerns the gene ERBB2 and primary biliary cholangitis.